Table 1 Population characteristics at baseline
Total | Proactive | Reactive | p-value | |
|---|---|---|---|---|
N = 586 | npro = 303 | nre = 283 | ||
Gender: women (%, n/N) | 78 (457/586) | 79 (238/303) | 77 (219/283) | .734* |
Age groups (%, n/N): | ||||
≤ 34 | 20 (115/576) | 21 (64/301) | 19 (51/275) | .118* |
35-49 | 25 (142/576) | 27 (82/301) | 22 (60/275) | |
50-64 | 39 (223/576) | 38 (114/301) | 40 (109/275) | |
≥ 65 | 17 (96/576) | 14 (41/301) | 20 (55/275) | |
Education in years (%, n/N): | ||||
0-9 | 25 (142/570) | 23 (67/296) | 27 (75/274) | .400* |
10-12 | 42 (237/570) | 42 (125/296) | 41 (112/274) | |
≥ 13 | 33 (191/570) | 35 (104/296) | 32 (87/274) | |
Number of cig/day (data journal) (%, n/N): | ||||
0 | 27 (131/482) | 24 (60/248) | 30 (71/234) | .268* |
1-14 | 34 (163/482) | 36 (90/248) | 31 (73/234) | |
≥ 15 | 39 (188/482) | 39 (98/248) | 39 (90/234) | |
No smoking the past seven days at baseline (%, n/N) | 28 (161/583) | 26 (78/301) | 29 (83/282) | .342* |
Number of years smoked before baseline (md, q1−q3, N) | 33, 18–40, 552 | 30, 16–40, 290 | 35, 20–43, 262 | .024† |
Stages-of-change (%, n/N): | ||||
-precontemplation/contemplation | 19 (81/433) | 18 (41/229) | 20 (40/204) | .872* |
-preparation | 29 (127/433) | 30 (69/229) | 28 (58/204) | |
-action | 52 (225/433) | 52 (119/229) | 52 (106/204) | |
Exposed to passive smoking (%, n/N) | 26 (142/552) | 28 (81/285) | 23 (61/267) | .134* |
Drug use (NRT, Zyban®, Champix®) the week before baseline (%, n/N) | 52 (294/568) | 53 (156/295) | 51 (138/273) | .578* |
Snus use the week before baseline (%, n/N) | 7 (36/526) | 9 (24/274) | 5 (12/252) | .070* |
Other support (%, n/N): | ||||
- none | 28 (162/574) | 28 (82/296) | 29 (80/278) | .600* |
- social | 46 (264/574) | 44 (131/296) | 48 (133/278) | |
- professional | 11 (60/574) | 12 (35/296) | 9 (25/278) | |
- social + professional | 15 (88/574) | 16 (48/296) | 14 (40/278) | |
High level of client satisfaction at first contact (%, n/N)‡ | 81 (447/554) | 79 (228/288) | 82 (219/266) | .346* |
Probability for being smokefree in one year (1–10) (md, q1−q3, N) | 8, 7–10, 564 | 9, 7–10, 292 | 8, 7–10, 272 | .209† |
Handle stress and depression successfully without smoking ( 1–10) (md, q1−q3, N) | 7, 4–9, 564 | 7, 4–9, 293 | 7, 4–9, 271 | .565† |
Will use pharmaceuticals if necessary (1–10) (md, q1−q3, N) | 9, 5–10, 566 | 9, 5–10, 293 | 10, 5–10, 273 | 739† |